These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38298137)

  • 1. Genetic and Epigenetic Landscape for Drug Development in Polycystic Ovary Syndrome.
    Chen Y; Wang G; Chen J; Wang C; Dong X; Chang HM; Yuan S; Zhao Y; Mu L
    Endocr Rev; 2024 Jul; 45(4):437-459. PubMed ID: 38298137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic Ovary Syndrome: the Epigenetics Behind the Disease.
    Eiras MC; Pinheiro DP; Romcy KAM; Ferriani RA; Reis RMD; Furtado CLM
    Reprod Sci; 2022 Mar; 29(3):680-694. PubMed ID: 33826098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic/circadian clocks and PCOS.
    Vatier C; Christin-Maitre S
    Hum Reprod; 2024 Jun; 39(6):1167-1175. PubMed ID: 38600622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a competing endogenous RNA network to identify drug targets against polycystic ovary syndrome.
    Wu T; Gao YY; Tang XN; Li Y; Dai J; Zhou S; Wu M; Zhang JJ; Wang SX
    Hum Reprod; 2022 Nov; 37(12):2856-2866. PubMed ID: 36223608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process.
    Mimouni NEH; Paiva I; Barbotin AL; Timzoura FE; Plassard D; Le Gras S; Ternier G; Pigny P; Catteau-Jonard S; Simon V; Prevot V; Boutillier AL; Giacobini P
    Cell Metab; 2021 Mar; 33(3):513-530.e8. PubMed ID: 33539777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic inheritance of polycystic ovary syndrome - challenges and opportunities for treatment.
    Stener-Victorin E; Deng Q
    Nat Rev Endocrinol; 2021 Sep; 17(9):521-533. PubMed ID: 34234312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epigenetics of polycystic ovary syndrome].
    Concha C F; Sir P T; Recabarren SE; Pérez B F
    Rev Med Chil; 2017 Jul; 145(7):907-915. PubMed ID: 29182200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Marks in Polycystic Ovary Syndrome.
    Motta AB
    Curr Med Chem; 2020; 27(39):6727-6743. PubMed ID: 31580245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics in polycystic ovary syndrome: a pilot study of global DNA methylation.
    Xu N; Azziz R; Goodarzi MO
    Fertil Steril; 2010 Jul; 94(2):781-3.e1. PubMed ID: 19939367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation in polycystic ovary syndrome: Emerging evidence and challenges.
    Liu YN; Qin Y; Wu B; Peng H; Li M; Luo H; Liu LL
    Reprod Toxicol; 2022 Aug; 111():11-19. PubMed ID: 35562068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-omics insights and therapeutic implications in polycystic ovary syndrome: a review.
    Babu A; Ramanathan G
    Funct Integr Genomics; 2023 Apr; 23(2):130. PubMed ID: 37079114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Genetics, Epigenetics and Lifestyle in Polycystic Ovary Syndrome Development: the State of the Art.
    Bruni V; Capozzi A; Lello S
    Reprod Sci; 2022 Mar; 29(3):668-679. PubMed ID: 33709373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epigenomics of polycystic ovarian syndrome: from pathogenesis to clinical manifestations.
    Li S; Zhu D; Duan H; Tan Q
    Gynecol Endocrinol; 2016 Dec; 32(12):942-946. PubMed ID: 27425146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity.
    Dunaif A
    J Clin Endocrinol Metab; 2016 Mar; 101(3):759-68. PubMed ID: 26908109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic Ovary Syndrome-Epigenetic Mechanisms and Aberrant MicroRNA.
    Ilie IR; Georgescu CE
    Adv Clin Chem; 2015; 71():25-45. PubMed ID: 26411410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathomechanisms of polycystic ovary syndrome: Multidimensional approaches.
    Sagvekar P; Dadachanji R; Patil K; Mukherjee S
    Front Biosci (Elite Ed); 2018 Mar; 10(3):384-422. PubMed ID: 29293465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A subpathway-based method of drug reposition for polycystic ovary syndrome.
    Liu HY; Liu JQ; Mai ZX; Zeng YT
    Reprod Sci; 2015 Apr; 22(4):423-30. PubMed ID: 25015903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of genome-wide DNA methylation across human polycystic ovary syndrome ovary granulosa cell.
    Xu J; Bao X; Peng Z; Wang L; Du L; Niu W; Sun Y
    Oncotarget; 2016 May; 7(19):27899-909. PubMed ID: 27056885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic and epigenetic factors of polycystic ovary syndrome].
    Herczeg Z; Vanya M; Szili K; Dézsi C; Nagy Z; Szabó J
    Orv Hetil; 2016 Aug; 157(32):1275-81. PubMed ID: 27499286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why are women with polycystic ovary syndrome obese?
    Barber TM
    Br Med Bull; 2022 Sep; 143(1):4-15. PubMed ID: 35284917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.